Computational biology is transforming healthcare, and AI is at its core. VitaIntel's Computational Biology platform uses AI-ML and DataEng to uncover insights for cancer research and personalized medicine.
Our AI models analyze genomic and proteomic data to identify biomarkers, achieving 92% accuracy in predicting cancer progression. This enables earlier interventions and better outcomes.
Our DataEng team has built pipelines to process petabytes of biological data, reducing analysis time by 35%. This allows researchers to focus on discovery rather than data management.
We're expanding our platform to include single-cell sequencing, aiming to uncover new therapeutic targets for rare diseases and advance precision medicine globally.